News
News Center
Jiuzhitang Maker makes its debut at the 2025 Wuzhen Health Conference, paving the way for innovative advancements in the stem cell field.
2025-04-16
On April 12, 2025, the 2025 Wuzhen Health Conference successfully concluded in Wuzhen. This year's event, themed "Towards Spring: Endogenous and Exogenous Forces Amidst Transformation," brought together key players from China's health industry ecosystem, creating an unforgettable annual showcase of the pharmaceutical and healthcare sectors. As a leader in the stem-cell field, Jiuzhitang Maker demonstrated exceptional strength at the conference, highlighting the vibrant spirit of innovation and tradition that defines this time-honored Chinese pharmaceutical brand—Jiuzhitang—and injecting fresh energy and fresh perspectives into the industry's ongoing evolution.
With far-reaching vision, expert insights resonate deeply within the industry.
During the conference forum session, Dr. Gao Yansong, General Manager of Jiuzhitang Maker, delivered a compelling speech titled "Stem Cell Therapy: The Key to Health and Beauty—Only Robust Quality Can Ensure Success," which became one of the event's main highlights. Dr. Gao emphasized that stem cell therapy, with its unique capabilities in immune modulation and inflammation suppression, holds tremendous potential in both disease treatment and health management. Numerous research findings have demonstrated significant therapeutic benefits of stem cells in areas such as stroke, lung diseases, diabetes, neurodegenerative disorders, and skin regeneration, offering renewed hope for recovery to countless patients—and gradually establishing stem cell therapy as a rising powerhouse in the medical and healthcare sector.
Dr. Gao emphasized particularly that the production of stem cell injectables carries inherent risks, including contamination, cross-contamination, errors, and potential mix-ups—risks that seriously jeopardize the safety and efficacy of treatments. Therefore, it is imperative to rigorously adhere to GMP standards and implement comprehensive, meticulous controls across every step of the stem cell manufacturing process. He innovatively proposed three core criteria for "high-quality" stem cells: first, safety, which is the fundamental prerequisite directly tied to patients' lives and health; second, efficacy, the therapy's ultimate goal and the very essence of its value; and third, quality control, serving as the critical safeguard that ensures both safety and effectiveness, guaranteeing each batch of stem cell products meets consistently reliable and stable quality standards. This well-structured and insightful framework has earned high praise from industry experts, pharmaceutical leaders, business executives, industry elites, and hospital directors in attendance, offering invaluable guidance for the sector's future development while sparking widespread, thought-provoking discussions.
Strength shines through as core products grab widespread attention.
At the exhibition, Jiuzhitang Maker’s core products—such as its human bone marrow mesenchymal stem cell injection—immediately caught the attention of numerous pharmaceutical experts and industry leaders as soon as they were unveiled at the booth. Thanks to their outstanding R&D achievements and cutting-edge technology, these innovations quickly drew crowds of eager visitors, sparking vibrant discussions and enthusiastic collaboration talks. With its deep-rooted scientific expertise and forward-thinking product vision, Jiuzhitang Maker became the center of attention at the event, laying a solid foundation for the future commercialization and market expansion of its stem-cell-based pharmaceuticals and cosmetic offerings.
In the future, Jiuzhitang Maker will continue to uphold its spirit of innovation and remain deeply committed to excellence in the stem cell field. The company will steadily increase its investment in research and development, strengthen collaboration with both domestic and international research institutions and medical organizations, and continuously enhance its scientific capabilities and product quality—all while striving to drive the high-quality growth of China’s health industry.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy